CONTACT: BECKY SOGLIN
Iowa City IA 52242
(319) 335-6660; fax (319) 384-4638
STUDY CONTACT: TRACY PETERS
Release: Jan. 22, 2003
UI invites women to participate in cervical cancer vaccine study
Women ages 16 to 23 are invited to participate in a University
of Iowa Health Care clinical trial to help determine the effectiveness and
safety of a vaccine for human papillomavirus (HPV). The virus is associated
with most cases of cervical cancer.
Women interested in participating in the trial must be in general good health
and must not be pregnant or planning to conceive during the first seven months
of the study. Participants must be willing to make approximately eight visits
to the UI Family Planning Clinic at UI Hospitals and Clinics. Over the course
of the study, participants will receive three injections of either vaccine
or a placebo.
Follow-up includes up to four years of gynecological exams that will test
for the presence of HPV infection or precancerous cells. In addition, routine
gynecologic care, contraception and compensation will be provided.
The study is led by Kevin A. Ault, M.D., UI assistant professor of obstetrics
and gynecology, who has led previous UI studies on cervical cancer vaccines.
An effective vaccine will likely include several HPV strains.
For more information, call Tracy Peters, UI research nurse, at (319) 384-4531
and ask about the HPV vaccine trial.
University of Iowa Health Care describes the partnership between
the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and
Clinics and the patient care, medical education and research programs and
services they provide. Visit UI Health Care online at www.uihealthcare.com.